Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans
Open Access
- 1 January 1983
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 23 (1), 1-7
- https://doi.org/10.1128/aac.23.1.1
Abstract
The mechanisms of the renal excretion of AM-715, a synthetic antimicrobial agent, were studied in rabbits, dogs, and humans. In both rabbits and humans, AM-715 clearance was greater than creatinine clearance and was profoundly decreased by the administration of probenecid. Thus, in these subjects, AM 715 was cleared by both tubular secretion and glomerular filtration. In dogs, however, the excretion ratio (close to unity), biological half-life, and stop-flow pattern of AM-715 were not affected by probenecid, indicating that the renal excretion of AM-715 took place mostly through glomerular filtration. These results suggest that renal excretion of AM-715 differs with animal species.This publication has 7 references indexed in Scilit:
- Clinical Pharmacokinetics of ProbenecidClinical Pharmacokinetics, 1981
- Comparative Activities of AM-715 and Pipemidic and Nalidixic Acids Against Experimentally Induced Systemic and Urinary Tract InfectionsAntimicrobial Agents and Chemotherapy, 1981
- In Vitro Antibacterial Activity of AM-715, a New Nalidixic Acid AnalogAntimicrobial Agents and Chemotherapy, 1980
- Influence of Probenecid on Serum Levels and Urinary Excretion of CinoxacinAntimicrobial Agents and Chemotherapy, 1979
- Cinoxacin: Pharmacokinetics and the Effect of ProbenecidThe Journal of Clinical Pharmacology, 1978
- RENAL EFFECTS OF BUMETANIDE1978
- A NEW SPECTROPHOTOMETRIC METHOD FOR THE DETECTION AND DETERMINATION OF KETO SUGARS AND TRIOSESJournal of Biological Chemistry, 1951